Ichimoku entry PAHCChose this one today because another unusual trigger, the lagging span breaking the cloud top. Trying to showcase different entry looks.
0.3EUR
29.89 MEUR
896.54 MEUR
20.23 M
About PHIBRO ANIMAL HEALTH A
Sector
CEO
Jack C. Bendheim
Headquarters
Teaneck
Website
Employees (FY)
1.92 K
Founded
1946
ISIN
US71742Q1067
FIGI
BBG006B68HB2
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
PAHC: One's Meat Or Poison ?PAHC has been consolidating some of its gains since its near term low formed in Apr 2017.
Prices appears to be forming a 3 wave A-B-C correction which might have already been completed or sub-divide a bit down further before resuming its uptrend.
Average turnover has been decreasing steadily since
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PHIBRO ANIMAL HEALTH A stocks are traded under the ticker PB8.
PHIBRO ANIMAL HEALTH A is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for PHIBRO ANIMAL HEALTH A has a max estimate of 12.0 EUR and a min estimate of 8.3 EUR.
PB8 earnings for the last quarter are 0.13 EUR whereas the estimation was 0.22 EUR which accounts for −39.13% surprise. Estimated earnings for the next quarter are 0.25 EUR. See more details about PHIBRO ANIMAL HEALTH A earnings.
PHIBRO ANIMAL HEALTH A revenue for the last quarter amounts to 218.81 M EUR despite the estimated figure of 228.93 M EUR. In the next quarter revenue is expected to reach 218.28 M EUR.
Yes, you can track PHIBRO ANIMAL HEALTH A financials in yearly and quarterly reports right on TradingView.
Like other stocks, PB8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHIBRO ANIMAL HEALTH A stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 1.92 K employees. See our rating of the largest employees — is PHIBRO ANIMAL HEALTH A on this list?
We've gathered analysts' opinions on PHIBRO ANIMAL HEALTH A future price: according to them, PB8 price has a max estimate of 11.97 EUR and a min estimate of 8.29 EUR. Read a more detailed PHIBRO ANIMAL HEALTH A forecast: see what analysts think of PHIBRO ANIMAL HEALTH A and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHIBRO ANIMAL HEALTH A EBITDA is 83.94 M EUR, and current EBITDA margin is 11.66%. See more stats in PHIBRO ANIMAL HEALTH A financial statements.